CAV1 and triple-negative breast carcinoma: These findings are supported by previous reports showing that caveolin 1 and 2 expression is associated with highly aggressive tumours such as inflammatory breast carcinoma (Eynden, 2005), basal-like (Savage et al, 2007, 2008) and triple-negative breast carcinoma (Shack et al, 2003; Tan et al, 2007; Savage et al, 2007, 2008).